Al Hammadi Holding Co
SAU:4007
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
41.95
69
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Al Hammadi Holding Co
Cost of Revenue
Al Hammadi Holding Co
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Al Hammadi Holding Co
SAU:4007
|
Cost of Revenue
-ď·Ľ744.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-11%
|
|
|
Dallah Healthcare Company SJSC
SAU:4004
|
Cost of Revenue
-ď·Ľ1.9B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-15%
|
|
|
National Medical Care Company JSC
SAU:4005
|
Cost of Revenue
-ď·Ľ753.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
|
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
Cost of Revenue
-ď·Ľ1.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-12%
|
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Cost of Revenue
-ď·Ľ6.2B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Cost of Revenue
-ď·Ľ1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Al Hammadi Holding Co
Glance View
Al Hammadi Holding engages in the management and operations of hospitals and medical centers. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2014-07-14. The Company’s activities include wholesale and retail trading of medical equipment, pharmaceutical and cosmetic products, establishing, maintaining, managing and operating hospitals and medical centers, wholesale and retail trading of food and beverages, acquisition and rental of land for constructing buildings and investing them by means of selling or renting in favor of the Group, establishment or participation in different industrial projects, establishment of commercial centers, operating, and maintaining them in Saudi Arabia, among others. The firm operates approximately three hospitals. The Company’s subsidiaries include Medical Support Services Company Limited, Pharmaceutical Services Company Limited, Al-Hammadi for Hospitals Operations and Management Company Limited, and Medical Industries Company Limited.
See Also
What is Al Hammadi Holding Co's Cost of Revenue?
Cost of Revenue
-744.6m
SAR
Based on the financial report for Jun 30, 2024, Al Hammadi Holding Co's Cost of Revenue amounts to -744.6m SAR.
What is Al Hammadi Holding Co's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-11%
Over the last year, the Cost of Revenue growth was 0%. The average annual Cost of Revenue growth rates for Al Hammadi Holding Co have been -9% over the past three years , -1% over the past five years , and -11% over the past ten years .
You don't have any saved screeners yet
